Eliot Lurier

Eliot Lurier

Nessuna posizione attualmente

66 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Eliot M.
Lurier
worked as a Chief Financial Officer, Treasurer, VP, and Head-Investor Relations in various pharmaceutical and biotech companies such as BioMarin Pediatrics II, Inc., Interleukin Genetics, Inc., NUCRYST Pharmaceuticals Corp., and Marker Therapeutics, Inc. He also worked as an Auditor at Coopers & Lybrand Sp zoo.
Lurier served as the Chief Financial Officer at Joslin Diabetes Center, Inc. for eight years.
He also worked as the Chief Financial Officer at Admetric Biochem, Inc. and as the Chief Operating & Financial Officer at Bridge Pharmaceuticals, Inc. Lurier is currently working as the Chief Financial Officer at Mustang Bio, Inc. and SomaLogic, Inc. respectively.
Lurier completed his undergraduate degree from Syracuse University in 1980.

Precedenti posizioni note di Eliot Lurier

SocietàPosizioneFine
MUSTANG BIO, INC. Director of Finance/CFO 08/12/2023
TENAX THERAPEUTICS, INC. Director of Finance/CFO 08/12/2023
STANDARD BIOTOOLS INC. Director of Finance/CFO 08/12/2023
MARKER THERAPEUTICS, INC. Director of Finance/CFO 17/11/2023
Director of Finance/CFO 01/04/2022
Vedi nel dettaglio l'esperienza di Eliot Lurier

Formazione di Eliot Lurier

Syracuse University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Eliot Lurier

Relazioni

100 +

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
TENAX THERAPEUTICS, INC.

Health Technology

MARKER THERAPEUTICS, INC.

Health Technology

MUSTANG BIO, INC.

Health Technology

STANDARD BIOTOOLS INC.

Commercial Services

Aziende private8

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Admetric Biochem, Inc.

Finance

Vedi le connessioni aziendali